Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Hidden Hearing Loss and Vestibular Damage Induced by Anti-cancer Treatments

NCT06490029 is registered in ClinicalTrials.gov with Direction Centrale du Service de Santé des Armées as lead sponsor.

NCT NCT06490029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06490029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Hidden Hearing Loss and Vestibular Damage Induced by Anti-cancer Treatments
Lead sponsor
Direction Centrale du Service de Santé des Armées
Phase
Observational
Overall status
Recruiting
Start date
June 19, 2024
Completion date
September 19, 2027
Enrollment
540 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ototoxicity, drug-induced